Mesoblast | MSB - Operating Profit

Stock Price
2.42
Daily Change
-0.06 -2.23%
Monthly
-11.86%
Yearly
-17.29%
Q1 Forecast
2.48

Mesoblast reported $-42.11M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Avita Medical AUD -11.15M 1.19M Jun/2025
Clinuvel Pharmaceuticals AUD 39.05M 21.49M Jun/2024
Cochlear AUD 125.55M 149.05M Jun/2025
CSL USD 666M 1.31B Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
PYC Therapeutics AUD -13.47M 12.42M Jun/2025
Ramsay Health Care AUD 537.2M 337.2M Jun/2025
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Starpharma Holdings AUD -2.3M 3.09M Jun/2025
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024